Primary fibroblast resiliency as a predictor of health and lifespan in mice

原代成纤维细胞弹性作为小鼠健康和寿命的预测因子

基本信息

  • 批准号:
    9422077
  • 负责人:
  • 金额:
    $ 30.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

In response to RFA-AG-17-040, “Short-term Measurements of Physical Resilience as a Predictor of Healthspan in Mice”, we propose testing primary fibroblast resilience with a panel of different cellular insults as a means to predict individual mouse longevity and healthspan. As outlined by the funding announcement for this RFA, there is a need to develop these standardized tests for use among the aging community to accelerate research towards revealing mechanisms that underly the physiological decline of aging. We previously have shown that primary fibroblasts isolated from the tail skin of mice likely retain characteristics of the in vivo environment of the mouse (or other species) from which they were established. For example, we showed in a series of studies that skin- derived primary fibroblasts isolated from long-lived mice with deficiencies in growth hormone/insulin- like growth factor 1 levels are resilient to multiple cytotoxic and metabolic insults. These differences persist even after numerous population doublings in culture using identical conditions as fibroblast lines from control mice. In addition, we have shown in this fibroblast model that resiliency to one form of insult predicts resiliency to multiple other forms of insult in an individual cell line. Our overall hypothesis is that cellular resiliency of skin-derived primary fibroblasts represents the vitality of an individual in vivo and predicts both healthspan and longevity of individual mice. We have designed this study to test this hypothesis and meet the goals outlined by this RFA. In our first aim, we test whether fibroblast resiliency is predictive of individual longevity and healthspan in a normally aging group of genetically heterogeneous mice. Because of the unique fibroblast resiliency panel of tests we have outlined, we can test physical resiliency of mice with little to no effect on the overall health and longevity of the animals. That is, in an individual mouse we will measure fibroblast resilience (including repeated assessments throughout middle age) and longevity and use these data to develop a predictive model. In our second aim, we test the effect on fibroblast resiliency of interventions in mice known to alter longevity and/or healthspan. This will test whether this model can predict novel interventions that may alter these parameters within a population. Because we currently lack standardized research tools to probe resiliencies at the cellular level, this marker of resilience has the potential to be a highly important marker of healthspan and longevity in mouse studies.
根据RFA-AG-17-040的要求,“身体复原力的短期测量 小鼠健康寿命的预测指标“,我们建议用一组 不同的细胞侮辱作为预测小鼠个体寿命和健康寿命的一种手段。如上所述 根据这个RFA的资金声明,有必要为以下方面开发这些标准化测试 在老龄化社区中使用,以加快研究,以揭示 衰老的生理性衰退。我们之前已经证明,从 小鼠的尾部皮肤可能保留了小鼠(或其他动物)体内环境的特征 物种),它们就是从这些物种建立起来的。例如,我们在一系列研究中表明,皮肤- 从生长激素/胰岛素缺乏的长寿小鼠分离的原代成纤维细胞- 像生长因子1一样,水平对多种细胞毒性和新陈代谢的侮辱具有弹性。这些差异 即使在使用与成纤维细胞相同的条件的培养中进行多次群体倍增后,仍然存在 来自对照小鼠的线条。此外,我们已经在这个成纤维细胞模型中展示了对一种形式的弹性 在一个单独的细胞系中,对多种其他形式的侮辱的恢复力。我们的整体 假说是,皮肤来源的原代成纤维细胞的细胞弹性代表了 个体在体内,并预测个体小鼠的健康寿命和寿命。我们设计了 这项研究旨在检验这一假设,并达到这一RFA概述的目标。在我们的第一个目标中,我们测试 在正常衰老中,成纤维细胞的弹性是否可以预测个体的寿命和健康寿命 一组遗传上不同的小鼠。因为独特的成纤维细胞弹性测试小组 我们已经概述了,我们可以测试小鼠的身体弹性,而对整体健康几乎没有影响 以及动物的长寿。也就是说,我们将在单个小鼠身上测量成纤维细胞的弹性 (包括中年期间的重复评估)和寿命,并使用这些数据 开发一个预测性模型。在我们的第二个目标中,我们测试了对成纤维细胞弹性的影响 对已知可改变寿命和/或健康寿命的小鼠的干预。这将测试该模型是否可以 预测可能改变人群中这些参数的新干预措施。因为我们目前 缺乏标准化的研究工具来探索细胞水平的弹性,这是弹性的标志 在小鼠研究中有可能成为健康和长寿的一个非常重要的标志。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adam Salmon其他文献

Adam Salmon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adam Salmon', 18)}}的其他基金

mTOR-Mediated Desaturation of Fatty Acids in Hepatic Insulin Resistance.
mTOR 介导的肝胰岛素抵抗中脂肪酸去饱和。
  • 批准号:
    10339318
  • 财政年份:
    2021
  • 资助金额:
    $ 30.94万
  • 项目类别:
mTOR-Mediated Desaturation of Fatty Acids in Hepatic Insulin Resistance.
mTOR 介导的肝胰岛素抵抗中脂肪酸去饱和。
  • 批准号:
    10554280
  • 财政年份:
    2021
  • 资助金额:
    $ 30.94万
  • 项目类别:
mTOR-Mediated Desaturation of Fatty Acids in Hepatic Insulin Resistance.
mTOR 介导的肝胰岛素抵抗中脂肪酸去饱和。
  • 批准号:
    10013714
  • 财政年份:
    2021
  • 资助金额:
    $ 30.94万
  • 项目类别:
The role of mTOR inhibition on longevity and healthy aging in a non-human primate
mTOR 抑制对非人类灵长类动物寿命和健康衰老的作用
  • 批准号:
    9145150
  • 财政年份:
    2015
  • 资助金额:
    $ 30.94万
  • 项目类别:
RC1: Pre-Clinical Research Core
RC1:临床前研究核心
  • 批准号:
    10221556
  • 财政年份:
    2015
  • 资助金额:
    $ 30.94万
  • 项目类别:
RC1: Pre-Clinical Research Core
RC1:临床前研究核心
  • 批准号:
    10455767
  • 财政年份:
    2015
  • 资助金额:
    $ 30.94万
  • 项目类别:
The role of mTOR inhibition on longevity and healthy aging in a non-human primate
mTOR 抑制对非人类灵长类动物寿命和健康衰老的作用
  • 批准号:
    9282387
  • 财政年份:
    2015
  • 资助金额:
    $ 30.94万
  • 项目类别:
RC1: Pre-Clinical Research Core
RC1:临床前研究核心
  • 批准号:
    10670135
  • 财政年份:
    2015
  • 资助金额:
    $ 30.94万
  • 项目类别:
RC1: Pre-Clinical Research Core
RC1:临床前研究核心
  • 批准号:
    10028131
  • 财政年份:
  • 资助金额:
    $ 30.94万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 30.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了